ANTICOAGULATION WITH VITAMIN K ANTAGONISTS VERSUS ANTIPLATELET THERAPY EARLY AFTER BIOPROSTHETIC VALVE IMPLANTATION IN THE PREVENTION OF THROMBOEMBOLISM: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Autor:	Ferdinand Gerodias, Jay Datukan, Sue Ann Locnen, Patricia Mariano, Anthony Gerodias
Rok vydání:	2018
Předmět:	medicine.medical_specialty Aspirin business.industry Vitamin k law.invention Bioprosthetic valve Randomized controlled trial law Meta-analysis Internal medicine Cardiology Medicine Cardiology and Cardiovascular Medicine business Medical therapy medicine.drug
Zdroj:	Journal of the American College of Cardiology. 71:A1987
ISSN:	0735-1097
DOI:	10.1016/s0735-1097(18)32528-2
Popis:	The optimum medical therapy in the 1st 3 months after surgical bioprosthetic valve implantation (BVI) remains controversial. Current guidelines of the American College of Cardiology recommend anticoagulation with vitamin K antagonists (VKA) (level IIa) or antiplatelet (AP) using aspirin (level IIa)
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7b59b8a8bb4e9963de4ffd2c0002ab3b https://doi.org/10.1016/s0735-1097(18)32528-2 Zobrazit plný text záznamu